Differential Approaches to The Management of Acute Bronchitis and Community-Acquired Pneumonia in Pediatric Patients

Yunusova Rano Tulkunovna

doi:10.51699/cajmns.v7i3.3254

Authors

Yunusova Rano Tulkunovna Associate Professor of the Department of Hospital Pediatrics and Folk Medicine, Tashkent State Medical University

DOI:

https://doi.org/10.51699/cajmns.v7i3.3254

Keywords:

Acute Bronchitis, Community Acquired Pneumonia, Children, Pediatric Respiratory Infections, Antibiotic Therapy, Differential Diagnosis, Respiratory Diseases

Abstract

Acute bronchitis and community acquired pneumonia remain among the most common respiratory diseases in pediatric practice, frequently creating diagnostic and therapeutic difficulties because of their overlapping clinical manifestations. The present study aimed to evaluate the clinical differences and treatment approaches in children diagnosed with these conditions while emphasizing the importance of differentiated management. A comparative clinical analysis was conducted among 86 pediatric patients aged 2 to 14 years who were divided into bronchitis and pneumonia groups according to clinical, laboratory, and radiological findings. The results demonstrated that pneumonia was associated with more severe inflammatory response, prolonged fever, respiratory impairment, and longer hospitalization, whereas most bronchitis cases responded successfully to supportive therapy without routine antibiotic administration. The study additionally highlighted the importance of careful differential diagnosis and rational antibacterial use in pediatric respiratory infections. Early identification of pneumonia combined with evidence based therapeutic strategies may improve clinical outcomes and reduce unnecessary antimicrobial exposure in children.

References

World Health Organization, Pneumonia in children, Geneva, Switzerland: WHO, 2023.

T. A. Florin, L. Ambroggio, C. Brokamp, et al., “Antibiotic use and outcomes in children with acute respiratory infections,” Pediatrics, vol. 149, no. 4, p. e2021053078, 2022.

N. Principi and S. Esposito, “Management of severe community-acquired pneumonia of children in developing and developed countries,” Thorax, vol. 76, no. 3, pp. 213–219, 2021.

J. S. Bradley, C. L. Byington, S. S. Shah, et al., “Executive summary: the management of community-acquired pneumonia in infants and children older than 3 months of age,” Clinical Infectious Diseases, vol. 76, no. 5, pp. e1–e18, 2023.

S. Jain, D. J. Williams, S. R. Arnold, et al., “Community-acquired pneumonia requiring hospitalization among children in the United States,” The New England Journal of Medicine, vol. 385, no. 15, pp. 1437–1446, 2021.

B. J. McMullan, D. Andresen, C. C. Blyth, et al., “Antibiotic duration and timing of switch from intravenous to oral route for bacterial infections in children,” The Lancet Child & Adolescent Health, vol. 6, no. 7, pp. 506–518, 2022.

M. J. Lipshaw, M. Eckerle, and T. A. Florin, “Differentiating viral from bacterial pneumonia in children,” Current Opinion in Pediatrics, vol. 35, no. 3, pp. 344–350, 2023.

M. A. Elemraid, S. P. Rushton, M. F. Thomas, et al., “Utility of inflammatory markers in predicting severe pediatric respiratory infections,” Pediatric Pulmonology, vol. 59, no. 1, pp. 91–99, 2024.

J. P. Donnelly, J. W. Baddley, and H. E. Wang, “Antibiotic utilization patterns in pediatric respiratory infections,” Journal of the Pediatric Infectious Diseases Society, vol. 11, no. 6, pp. 281–289, 2022.

T. Lynch, R. Platt, S. Gouin, et al., “Can we predict serious bacterial infections in children with respiratory symptoms?” Pediatrics, vol. 151, no. 4, p. e2022058817, 2023.

I. Rudan, K. L. O’Brien, H. Nair, et al., “Epidemiology and treatment outcomes of childhood pneumonia worldwide,” Lancet Respiratory Medicine, vol. 12, no. 2, pp. 101–114, 2024.

B. Mathews, S. Shah, R. H. Cleveland, et al., “Clinical predictors of pneumonia among children with wheezing,” Pediatrics, vol. 149, no. 5, p. e2021056031, 2022.

S. Rhedin, A. Lindstrand, M. Rotzén Östlund, et al., “Clinical utility of biomarkers in pediatric lower respiratory tract infections,” Frontiers in Pediatrics, vol. 10, p. 842258, 2022.

M. U. Bhuiyan, T. L. Snelling, R. West, et al., “The contribution of viral and bacterial infections to childhood pneumonia severity,” Clinical Microbiology and Infection, vol. 29, no. 5, pp. 641–648, 2023.

F. P. Havers, L. A. Hicks, J. R. Chung, et al., “Outpatient antibiotic prescribing patterns for acute respiratory infections in children,” JAMA Network Open, vol. 7, no. 1, p. e2351148, 2024.

H. J. Zar, S. Andronikou, and M. P. Nicol, “Advances in the diagnosis of pneumonia in children,” BMJ, vol. 377, p. e064707, 2022.